Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 6-MTH group results

Oct 30 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              132.21              129.49           293.50    
                   (+2.1 pct)          (-6.6 pct)       (+12.2 pct) 
  Operating           14.68               16.99            33.00    
                   (-13.6 pct)         (+11.9 pct)      (+5.7 pct)  
  Recurring           14.98               22.71            37.00    
                   (-34.1 pct)         (+27.2 pct)      (-9.4 pct)  
  Net                 14.98               42.43            29.50    
                   (-64.7 pct)        (+253.1 pct)      (-39.3 pct) 
  EPS              187.68 yen          531.62 yen       369.64 yen  
  EPS Diluted      187.47 yen          531.14 yen                   
  Ann Div                              120.00 yen       110.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               70.00 yen        60.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news